If you think HealthXCapital’s $25 million fund is a mere drop compared to larger vehicles targeting the Asian healthcare space – it is. Healthcare is awash with capital.
Sample this: Healthcare-focused private equity firm, Quadria Capital is raising $700 million for its second fund for emerging Asia. Singapore-based Altair Capital is targeting a $150 million maiden ASEAN fund covering healthcare, among other investments. China VCs like Quan Capital and Long Hill Capital are raising up to $300 million for their healthcare funds. Biotech and pharmas rule the exits with players like Wuxi AppTech and Tencent’s WeDoctor on track to launch HK IPOs worth over $1 billion.
